Published in Neurosci Lett on September 30, 2008
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain (2010) 2.37
Olfactory dysfunction in Parkinson disease. Nat Rev Neurol (2012) 1.73
Olfaction in Parkinson's disease and related disorders. Neurobiol Dis (2011) 1.51
The default mode network integrity in patients with Parkinson's disease is levodopa equivalent dose-dependent. J Neural Transm (Vienna) (2011) 1.02
Cholinergic dysfunction in Parkinson's disease. Curr Neurol Neurosci Rep (2013) 0.95
In vivo neurochemical imaging of olfactory dysfunction in Parkinson's disease. J Neural Transm (Vienna) (2012) 0.85
A cross-sectional study contrasting olfactory function in autonomic disorders. Neurology (2011) 0.84
Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene. Mov Disord (2015) 0.82
Performance on an Alzheimer-selective odor identification test in patients with Parkinson's disease and its relationship with cerebral dopamine transporter activity. Parkinsonism Relat Disord (2009) 0.80
Levodopa effects on [ (11)C]raclopride binding in the resting human brain. F1000Res (2015) 0.78
Regional, kinetic [(18)F]FDG PET imaging of a unilateral Parkinsonian animal model. Am J Nucl Med Mol Imaging (2013) 0.78
Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant α-synuclein. PLoS One (2015) 0.77
Adult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticity. Neural Plast (2014) 0.77
Relation between Olfactory Dysfunction and Episodic Verbal Memory in Early Parkinson's Disease. Noro Psikiyatr Ars (2014) 0.75
The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system. Transl Neurodegener (2017) 0.75
Olfactory dysfunction in persian patients suffering from parkinson's disease. Iran J Neurol (2011) 0.75
The Olfactory System Revealed: Non-Invasive Mapping by using Constrained Spherical Deconvolution Tractography in Healthy Humans. Front Neuroanat (2017) 0.75
New test of odor pleasantness in Parkinson's disease. Funct Neurol (2016) 0.75
Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson's disease. Sci Rep (2017) 0.75
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry (1992) 33.67
Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging (2002) 22.40
Dopamine neuron systems in the brain: an update. Trends Neurosci (2007) 4.44
Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab (2003) 3.77
Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology (1988) 2.72
The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging. Neuropathol Appl Neurobiol (2007) 2.38
Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol (2007) 2.08
Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry (1992) 1.50
Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease. J Neurol Neurosurg Psychiatry (1999) 1.47
Clinical assessment of olfactory dysfunction in Parkinson's disease. Mov Disord (1998) 1.44
[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology (2005) 1.30
Dopamine depresses synaptic inputs into the olfactory bulb. J Neurophysiol (1999) 1.30
A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol (2008) 1.29
A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord (2004) 1.25
Functional magnetic resonance imaging study of human olfaction and normal aging. J Gerontol A Biol Sci Med Sci (2005) 1.21
Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor. Behav Brain Res (2006) 1.21
Positron tomographic emission study of olfactory induced emotional recall in veterans with and without combat-related posttraumatic stress disorder. Psychopharmacol Bull (2007) 1.17
Dopamine modulation of hippocampal-prefrontal cortical interaction drives memory-guided behavior. Cereb Cortex (2007) 1.11
Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol (2003) 1.10
Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease. J Neurol (2007) 1.04
Olfactory dysfunction in Parkinson's disease. Neurosignals (2007) 1.04
Dopamine D(2) receptor activation modulates perceived odor intensity. Behav Neurosci (2006) 1.03
Spared caudal brainstem SERT binding in early Parkinson's disease. J Cereb Blood Flow Metab (2007) 1.02
Functional anatomy of human odor sensation, discrimination, and identification in health and aging. Neuropsychology (2003) 1.01
Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats. J Nucl Med (2007) 1.01
Opposing effects of D1 and D2 receptor activation on odor discrimination learning. Behav Neurosci (2004) 1.00
A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease. J Neurol (2008) 1.00
Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration. Psychopharmacology (Berl) (1989) 0.99
Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride. Mov Disord (1997) 0.97
Selective anosmia in Parkinson's disease? Lancet (1993) 0.92
Functional imaging of the cerebral olfactory system in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2007) 0.92
[Olfactory testing with "sniffin' sticks" for clinical diagnosis of Parkinson disease]. Nervenarzt (2000) 0.91
Cholinergic modulation of dopaminergic neurons in the mouse olfactory bulb. Chem Senses (2008) 0.89
Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease. Eur J Nucl Med Mol Imaging (2007) 0.89
Extracellular dopamine increases in the neonatal olfactory bulb during odor preference training. Brain Res (1991) 0.87
SKF 38393 enhances odor detection performance. Psychopharmacology (Berl) (1998) 0.83
Parkinson's disease and aging: same or different process? Mov Disord (2008) 0.82
Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol (2003) 1.94
Human regional cerebral glucose metabolism during non-rapid eye movement sleep in relation to waking. Brain (2002) 1.50
NF1 microduplications: identification of seven nonrelated individuals provides further characterization of the phenotype. Genet Med (2012) 1.49
In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study. Exp Neurol (2010) 1.47
Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol (2003) 1.16
Plasticity of the nigropallidal pathway in Parkinson's disease. Ann Neurol (2003) 1.13
Regional brain glucose metabolism during morning and evening wakefulness in humans: preliminary findings. Sleep (2004) 1.07
Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease. J Neurol (2007) 1.04
Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease. Neurosci Lett (2005) 0.99
Somatotopy and attentional modulation of the human parietal and opercular regions. J Neurosci (2004) 0.98
Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson's disease. Neurosci Lett (2007) 0.93
Diurnal variation in regional brain glucose metabolism in depression. Biol Psychiatry (2007) 0.92
Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease. Alzheimers Dement (2008) 0.92
Gamma Knife thalamotomy for essential tremor. J Neurosurg (2008) 0.91
Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study. Mov Disord (2014) 0.89
Lesions of suprachiasmatic nucleus efferents selectively affect rest-activity rhythm. Mol Cell Endocrinol (2006) 0.85
Age-associated striatal dopaminergic denervation and falls in community-dwelling subjects. J Rehabil Res Dev (2009) 0.82
Somatosensory areas engaged during discrimination of steady pressure, spring strength, and kinesthesia. Hum Brain Mapp (2003) 0.79
Therapeutic hypothermia for refractory status epilepticus in a child with malignant migrating partial seizures of infancy and SCN1A mutation: a case report. Ther Hypothermia Temp Manag (2012) 0.78
A Biohybrid Device for the Systemic Control of Acute Inflammation. Disrupt Sci Technol (2012) 0.76
Innervation of ventricular and periventricular brain compartments. Brain Res (2012) 0.76